Literature DB >> 27889190

Diagnosis of multiple sclerosis: progress and challenges.

Wallace J Brownlee1, Todd A Hardy2, Franz Fazekas3, David H Miller4.   

Abstract

The diagnosis of multiple sclerosis is based on neurological symptoms and signs, alongside evidence of dissemination of CNS lesions in space and time. MRI is often sufficient to confirm the diagnosis when characteristic lesions accompany a typical clinical syndrome, but in some patients, further supportive information is obtained from cerebrospinal fluid examination and neurophysiological testing. Differentiation is important from other diseases in which demyelination is a feature (eg, neuromyelitis optica spectrum disorder and acute disseminated encephalomyelitis) and from non-demyelinating disorders such as chronic small vessel disease and other inflammatory, granulomatous, infective, metabolic, and genetic causes that can mimic multiple sclerosis. Advances in MRI and serological and genetic testing have greatly increased accuracy in distinguishing multiple sclerosis from these disorders, but misdiagnosis can occur. In this Series paper we explore the progress and challenges in the diagnosis of multiple sclerosis with reference to diagnostic criteria, important differential diagnoses, controversies and uncertainties, and future prospects.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27889190     DOI: 10.1016/S0140-6736(16)30959-X

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  88 in total

Review 1.  The role of the gut microbiome in systemic inflammatory disease.

Authors:  Jose C Clemente; Julia Manasson; Jose U Scher
Journal:  BMJ       Date:  2018-01-08

2.  A Systematic Review of Discrete-Choice Experiments and Conjoint Analysis Studies in People with Multiple Sclerosis.

Authors:  Edward J D Webb; David Meads; Ieva Eskyte; Natalie King; Naila Dracup; Jeremy Chataway; Helen L Ford; Joachim Marti; Sue H Pavitt; Klaus Schmierer; Ana Manzano
Journal:  Patient       Date:  2018-08       Impact factor: 3.883

3.  [Inflammatory diseases of the central nervous system].

Authors:  Armin Bachhuber
Journal:  Radiologe       Date:  2021-06-08       Impact factor: 0.635

Review 4.  Misdiagnosis of multiple sclerosis: Impact of the 2017 McDonald criteria on clinical practice.

Authors:  Andrew J Solomon; Robert T Naismith; Anne H Cross
Journal:  Neurology       Date:  2018-10-31       Impact factor: 9.910

Review 5.  Multiple sclerosis.

Authors:  Massimo Filippi; Amit Bar-Or; Fredrik Piehl; Paolo Preziosa; Alessandra Solari; Sandra Vukusic; Maria A Rocca
Journal:  Nat Rev Dis Primers       Date:  2018-11-08       Impact factor: 52.329

6.  Hindsight is 20/20.

Authors:  Alexander T Moffett; Harry Hollander; Gail Berkenblit; Justin C McArthur; Reza Manesh
Journal:  J Hosp Med       Date:  2020-02-11       Impact factor: 2.960

Review 7.  Multiple Sclerosis.

Authors:  Daniel S Reich; Claudia F Lucchinetti; Peter A Calabresi
Journal:  N Engl J Med       Date:  2018-01-11       Impact factor: 91.245

Review 8.  [Diagnosis of multiple sclerosis: revision of the McDonald criteria 2017].

Authors:  O Aktas; M P Wattjes; M Stangel; H-P Hartung
Journal:  Nervenarzt       Date:  2018-12       Impact factor: 1.214

9.  Monocyte NOTCH2 expression predicts IFN-β immunogenicity in multiple sclerosis patients.

Authors:  Marsilio Adriani; Petra Nytrova; Cyprien Mbogning; Signe Hässler; Karel Medek; Poul Erik H Jensen; Paul Creeke; Clemens Warnke; Kathleen Ingenhoven; Bernhard Hemmer; Claudia Sievers; Raija Lp Lindberg Gasser; Nicolas Fissolo; Florian Deisenhammer; Zsolt Bocskei; Vincent Mikol; Anna Fogdell-Hahn; Eva Kubala Havrdova; Philippe Broët; Pierre Dönnes; Claudia Mauri; Elizabeth C Jury
Journal:  JCI Insight       Date:  2018-06-07

Review 10.  Imaging in Pediatric Multiple Sclerosis : An Iconographic Review.

Authors:  Gonzalo Barraza; Kumaran Deiva; Béatrice Husson; Catherine Adamsbaum
Journal:  Clin Neuroradiol       Date:  2020-07-16       Impact factor: 3.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.